Healthtech Series B Investors & VC Firms
1028 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Define Ventures
San FranciscoSeed–Series B$750K – $6M
25 people
Antler Australia
SydneyPre-Seed–Series C$3M – $10M
17 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
Galaxy Interactive
New YorkPre-Seed–Late Stage$1M – $20M
9 people
iSelect Fund
St. LouisSeed–Series B$250K – $2M
10 people
Karma Ventures
TallinnSeed–Series B$1.1M – $5.4M
14 people
venBio Partners
San FranciscoSeed–Series C
10 people
Kinnevik
StockholmSeed–Growth
20 people
Invest-NL
AmsterdamSeries A–Growth
23 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
26 people
Trousdale Ventures
West HollywoodSeed–Series B$1M – $5M
2 people
7wire Ventures
ChicagoSeed–Growth$100K – $5M
17 people
Samsung Catalyst Fund
San JoseSeed–Growth
14 people
Protagonist
Bay Harbor IslandsSeed–Growth$10K – $1M
7 people
YuanBio Venture Capital
SuzhouSeed–Growth
18 people
Jerusalem Venture Partners (JVP)
JerusalemSeed–Growth$1M – $5M
24 people
Fundamentum
GurugramSeries B–Series C$10M – $25M
16 people
Global Ventures
DubaiSeed–Growth$1M – $3M
13 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
Shanghai Healthcare Capital
ShanghaiSeed–Series B
45 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
McKesson Ventures
San FranciscoSeed–Growth
17 people
2050
ParisSeed–Growth
29 people
Fortune Venture Capital
ShenzhenSeed–Series C
11 people
Related lists
Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1358)
Data sourced from public filings and firms' own websites — see our methodology.



































































































